Reckling W Carlton 4
4 · SI-BONE, Inc. · Filed Aug 22, 2019
Insider Transaction Report
Form 4
SI-BONE, Inc.SIBN
Reckling W Carlton
CMO and VP, Medical Affairs
Transactions
- Sale
Common Stock
2019-08-20$20.01/sh−3,930$78,629→ 9,896 total - Exercise/Conversion
Common Stock
2019-08-21$3.96/sh+770$3,049→ 10,666 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-08-20−3,930→ 46,324 totalExercise: $3.96Exp: 2023-03-18→ Common Stock (3,930 underlying) - Sale
Common Stock
2019-08-21$20.03/sh−770$15,421→ 9,896 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-08-21−770→ 45,554 totalExercise: $3.96Exp: 2023-03-18→ Common Stock (770 underlying) - Exercise/Conversion
Common Stock
2019-08-20$3.96/sh+3,930$15,563→ 13,826 total
Footnotes (5)
- [F1]Includes 9,562 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock.
- [F2]The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
- [F3]The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.11, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
- [F4]The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.18, inclusive.
- [F5]The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.